Last reviewed · How we verify
thalidomide and megestrol acetate — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
thalidomide and megestrol acetate (thalidomide and megestrol acetate) — Shenzhen Fifth People's Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| thalidomide and megestrol acetate TARGET | thalidomide and megestrol acetate | Shenzhen Fifth People's Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- thalidomide and megestrol acetate CI watch — RSS
- thalidomide and megestrol acetate CI watch — Atom
- thalidomide and megestrol acetate CI watch — JSON
- thalidomide and megestrol acetate alone — RSS
Cite this brief
Drug Landscape (2026). thalidomide and megestrol acetate — Competitive Intelligence Brief. https://druglandscape.com/ci/thalidomide-and-megestrol-acetate. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab